• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025

    3/21/25 9:00:00 AM ET
    $ACCS
    $NXGL
    Publishing
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care
    Get the next $ACCS alert in real time by email

    RALEIGH, NC / ACCESS Newswire / March 21, 2025 / iAccess Alpha's Virtual Best Ideas Spring Investment Conference will take place on March 25-26, 2025, bringing together top micro-cap companies and investors for two days of high-quality insights and investing opportunities.

    The event begins on Tuesday, March 25, 2025, with a series of live-streamed company presentations, beginning at 9:30 AM ET. The following day, Wednesday, March 26, will be dedicated to 1x1 meetings between presenting companies and investors, starting at 8:00 AM ET.

    How to Attend:

    Investors and industry professionals can register to watch the presentations and request 1x1 meetings by visiting the official event website: Register Here

    Conference Schedule - March 25, 2025 (All Times ET):

    Time

    Company

    Ticker

    Webcast Link

    9:30am

    Nexgel Inc

    NASDAQ:NXGL

    View Presentation

    10:00am

    Data Storage Corp

    NASDAQ:DTST

    View Presentation

    10:30am

    Callan JMB Inc

    NASDAQ:CJMB

    View Presentation

    11:00am

    Intelligent Bio Solutions Inc

    NASDAQ:INBS

    View Presentation

    11:30am

    Birchtech Corp

    TSX:BCHT, OTCQB:BCHT

    View Presentation

    12:00pm

    Protalix Biotherapeutics Inc

    NASDAQ:PLX

    View Presentation

    12:30pm

    Vox Royalty Corp

    TSX:VOXR, NASDAQ:VOXR

    View Presentation

    1:00pm

    DoubleDown Interactive

    NASDAQ:DDI

    View Presentation

    1:30pm

    Assertio Holdings Inc

    NASDAQ:ASRT

    View Presentation

    2:00pm

    Intellicheck Inc

    NASDAQ:IDN

    View Presentation

    2:30pm

    ACCESS Newswire Inc

    NYSE American:ACCS

    View Presentation

    3:00pm

    Algorhythm Holdings Inc

    NASDAQ:RIME

    View Presentation

    About iAccess Alpha's Virtual Best Ideas Investment Conferences

    iAccess Alpha hosts four virtual investment conferences annually (March, June, September, and December), showcasing high-potential small and micro-cap investment opportunities. The conferences feature live company presentations on Day 1, followed by exclusive 1x1 investor meetings on Day 2. Since 2019, iAccess Alpha has co-organized leading microcap-focused events, connecting top-tier investors with high-potential companies.

    For more information, contact:
    [email protected]
    www.iaccessalpha.com

    SOURCE: iAccess Alpha



    View the original press release on ACCESS Newswire

    Get the next $ACCS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACCS
    $NXGL

    CompanyDatePrice TargetRatingAnalyst
    NexGel Inc
    $NXGL
    2/25/2022$6.00Buy
    Maxim Group
    More analyst ratings

    $ACCS
    $NXGL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Levy Adam R. bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 1% to 333,196 units (SEC Form 4)

      4 - NEXGEL, INC. (0001468929) (Issuer)

      11/22/24 4:54:14 PM ET
      $NXGL
      Medical/Dental Instruments
      Health Care
    • Director Zeldis Jerome B bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 4% to 106,664 units (SEC Form 4)

      4 - NEXGEL, INC. (0001468929) (Issuer)

      11/22/24 4:54:12 PM ET
      $NXGL
      Medical/Dental Instruments
      Health Care
    • Director Stein John Nachum gifted 4,000 shares and bought $9,999 worth of shares (3,636 units at $2.75), decreasing direct ownership by 0.08% to 471,456 units (SEC Form 4)

      4 - NEXGEL, INC. (0001468929) (Issuer)

      11/22/24 4:54:08 PM ET
      $NXGL
      Medical/Dental Instruments
      Health Care

    $ACCS
    $NXGL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Maxim Group initiated coverage on NexGel with a new price target

      Maxim Group initiated coverage of NexGel with a rating of Buy and set a new price target of $6.00

      2/25/22 9:17:01 AM ET
      $NXGL
      Medical/Dental Instruments
      Health Care

    $ACCS
    $NXGL
    SEC Filings

    See more
    • SEC Form 10-Q filed by ACCESS Newswire Inc.

      10-Q - ACCESS Newswire Inc. (0000843006) (Filer)

      5/13/25 5:02:55 PM ET
      $ACCS
      Publishing
      Consumer Discretionary
    • Amendment: ACCESS Newswire Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K/A - ACCESS Newswire Inc. (0000843006) (Filer)

      5/13/25 5:02:25 PM ET
      $ACCS
      Publishing
      Consumer Discretionary
    • SEC Form 10-Q filed by NexGel Inc

      10-Q - NEXGEL, INC. (0001468929) (Filer)

      5/13/25 5:00:29 PM ET
      $NXGL
      Medical/Dental Instruments
      Health Care

    $ACCS
    $NXGL
    Financials

    Live finance-specific insights

    See more
    • NEXGEL Reports First Quarter 2025 Financial Results

      First quarter 2025 revenue totaled $2.81 million, an increase of 121%, as compared to $1.27 million for the same period the prior year Gross Profit for the quarter was 42.4%, compared to 12.6% in Q1 2024 and 37.2% in Q4 2024 LANGHORNE, Pa., May 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced its first quarter 2025 financial results for the period ending March 31, 2025. First Quarter 2025 Financial Highlights: Net Revenue was $2.81 million, compared to $1.27 million in Q1 2024 and $3.04 million in Q4 2024.Gross Profit

      5/13/25 4:05:00 PM ET
      $NXGL
      Medical/Dental Instruments
      Health Care
    • NEXGEL to Report First Quarter 2025 Financial Results on May 13th

      Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the first quarter 2025, after the market close on May 13, 2025. Following the release of its financial results, the Company will host a conference call at 4:30 p.m. ET on the same day. First Quarter 2025 Financial Results Conference CallDate: May 13, 2025Time: 4:30 P.M. ETLive Call: 1-800-343-4849 (U.S. Toll Free) or 1-203-518-9848 (Internatio

      5/9/25 9:00:00 AM ET
      $NXGL
      Medical/Dental Instruments
      Health Care
    • NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

      Fourth quarter 2024 revenue totaled $3.04 million, an increase of 181%, as compared to $1.08 million for the same period the prior year Full year 2024 revenue totaled $8.69 million, an increase of 112%, as compared to $4.09 million in 2023 Over 100% full year and fourth quarter revenue growth year-over-year for third consecutive year Company issues revenue guidance of $13 million for 2025 and expects to achieve positive EBITDA during the year LANGHORNE, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced record

      3/24/25 4:05:00 PM ET
      $NXGL
      Medical/Dental Instruments
      Health Care

    $ACCS
    $NXGL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NEXGEL Reports First Quarter 2025 Financial Results

      First quarter 2025 revenue totaled $2.81 million, an increase of 121%, as compared to $1.27 million for the same period the prior year Gross Profit for the quarter was 42.4%, compared to 12.6% in Q1 2024 and 37.2% in Q4 2024 LANGHORNE, Pa., May 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced its first quarter 2025 financial results for the period ending March 31, 2025. First Quarter 2025 Financial Highlights: Net Revenue was $2.81 million, compared to $1.27 million in Q1 2024 and $3.04 million in Q4 2024.Gross Profit

      5/13/25 4:05:00 PM ET
      $NXGL
      Medical/Dental Instruments
      Health Care
    • NEXGEL to Report First Quarter 2025 Financial Results on May 13th

      Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the first quarter 2025, after the market close on May 13, 2025. Following the release of its financial results, the Company will host a conference call at 4:30 p.m. ET on the same day. First Quarter 2025 Financial Results Conference CallDate: May 13, 2025Time: 4:30 P.M. ETLive Call: 1-800-343-4849 (U.S. Toll Free) or 1-203-518-9848 (Internatio

      5/9/25 9:00:00 AM ET
      $NXGL
      Medical/Dental Instruments
      Health Care
    • NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th

      LANGHORNE, Pa., April 07, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will be presenting at the Planet MicroCap Showcase: Vegas 2025, taking place at the Paris Hotel & Casino, Las Vegas, NV on April 22-24, 2025. Planet MicroCap Showcase: Vegas 2025Presentation Date: Wednesday, April 23, 2025Presentation Time: 9:30 a.m. PT Location: Paris Hotel & Casino, Las Vegas, NV, in Track 4 - LoireWebcast: https://ir.nexgel.com/news-events/events-

      4/7/25 9:00:00 AM ET
      $NXGL
      Medical/Dental Instruments
      Health Care

    $ACCS
    $NXGL
    Leadership Updates

    Live Leadership Updates

    See more
    • NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

      LANGHORNE, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced the appointment of Joseph F. McGuire as Chief Financial Officer, effective January 1, 2025. Adam E. Drapczuk III, current Chief Financial Officer, will remain with the Company as a consultant. Adam Levy, Chief Executive Officer, stated, "As our business continues to experience high growth, it is imperative we consistently acquire talented and experienced professionals to join our team particularly in operati

      1/2/25 9:00:00 AM ET
      $NXGL
      Medical/Dental Instruments
      Health Care
    • NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

      LANGHORNE, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced the appointment of Kip Crecca to its Scientific Advisory Board. "We are thrilled to appoint Kip to our Scientific Advisory Board. He adds to our team a wealth of knowledge and experience as a top medical device sales professional," said Adam Levy, NEXGEL's CEO. "Mr. Crecca will be invaluable to the Company as we advance our medical device and healthcare programs. He is an important addition to our group of e

      10/4/24 9:00:00 AM ET
      $NXGL
      Medical/Dental Instruments
      Health Care
    • NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

      LANGHORNE, Pa., Jan. 17, 2023 /PRNewswire/ -- NEXGEL, Inc. (NASDAQ:NXGL, NXGLW))), ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today the appointment of Scott Henry, CFA as a new independent director to the Company's Board of Directors (the "Board"), effective immediately. Mr. Henry will also serve as a member of the Board's Audit Committee. "Scott brings a wealth of financial and operational experience to NEXGEL, making him an ideal addition to our Board and Audit Committee," said Adam Levy, Chief Executive Officer of NEXGEL. "Additionally, his vast network within the investment comm

      1/17/23 7:30:00 AM ET
      $NXGL
      Medical/Dental Instruments
      Health Care

    $ACCS
    $NXGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Henry Scott Robert sold $8,062 worth of shares (3,000 units at $2.69), decreasing direct ownership by 2% to 132,053 units (SEC Form 4)

      4 - NEXGEL, INC. (0001468929) (Issuer)

      5/13/25 8:00:04 PM ET
      $NXGL
      Medical/Dental Instruments
      Health Care
    • Director Henry Scott Robert sold $7,825 worth of shares (3,000 units at $2.61), decreasing direct ownership by 2% to 135,053 units (SEC Form 4)

      4 - NEXGEL, INC. (0001468929) (Issuer)

      4/14/25 5:00:18 PM ET
      $NXGL
      Medical/Dental Instruments
      Health Care
    • Chief Executive Officer Levy Adam R. sold $12,038 worth of shares (4,000 units at $3.01), decreasing direct ownership by 1% to 370,284 units (SEC Form 4)

      4 - NEXGEL, INC. (0001468929) (Issuer)

      4/2/25 5:00:26 PM ET
      $NXGL
      Medical/Dental Instruments
      Health Care